29.08.22
Spotify
Heather Allman talks with Michael Sassano of SOMAÍ Pharmaceuticals LTD about recent regulatory changes, the differences between Europe and US when it comes to GMP licensing.
27.08.22
YouTube – Ask GenieNansea
In this episode, SOMAÍ’s CEO, Michael Sassano, explains how he got involved in the industry, talks about his experience in the States so far and about SOMAÍ Pharmaceuticals.
22.08.22
BusinessCann
Michael Sassano, CEO of international cannabis manufacturer Somai Pharmaceuticals, explores the state of cannabis extract manufacturing in Europe and who is currently leading the pack.
16.08.22
Cannabis Science and Technology
In this article, Somai’s R&D Director, Anthony DeMeo, examines why we should be studying cannabinoids beyond THC and CBD to explore their potential medical value.
03.08.22
Consider Cannabis
02.08.22
Cannabis Law Report
Manufacturing process optimization aims to increase productivity, decrease operational costs, and make the manufacturing process more robust via a more stable, controlled analysis with fewer errors. We will concentrate on step-by-step improvements using the Plan, Do, Check, and Act (PDSA) methodology.
02.08.22
Anteprojectos
Como primeiro investimento da SOMAÍ em Portugal, foi apresentado um edifício com licença de armazém, com a pretensão de conversão do mesmo em edifício de uso industrial. Dado que as suas características já tinham a utilização mista de escritórios, zonas sociais com balneários e vestiários, o desafio era reconverter o edifício para uma nova utilização e com base nas normas legais em vigor para o uso proposto e as necessidades da atividade.
28.07.22
Omny Studio
Today’s episode has a decidedly European flavor: my guest is Michael Sassano, the Founder, Chairman and CEO of Somai Pharmaceuticals, a European pharmaceutical and biotech company centered on manufacturing in Lisbon, Portugal.
26.07.22
Technical420
I recently had a chance to visit Israel and learn about the Israeli cannabis market from the best growers and distributors. And yes — cannabis can indeed be Kosher. Like all countries, regulators have made progress and could do much more to support the industry growth and patients’ needs.